Healthcare investor and entrepreneur Steven Yecies has moved at the forefront of meaningful clinical and process change in healthcare in the U.S. and in major European, Asian and Middle Eastern markets through leadership roles at numerous firms. Most recently, he started and led the venture investments in healthcare IT at OrbiMed Advisors, a premier global investor in healthcare. He previously founded his own investment firm, Chronic Health Capital, which focused on private equity investments in healthcare IT and services, and established the health and wellness business at Scient (NASDAQ: SCNT), where he built more than 40 first generation e-health businesses for national health systems and leading global healthcare enterprises.
Yecies holds an MBA from Harvard Business School; a JD from the University of California, Berkeley; and an AB from Dartmouth College.
“Management of diabetes is a big problem. Mellitus Health’s ability to adjust all insulin prescriptions in ways that significantly lower blood glucose, without incidents of dangerous hypoglycemia, is what drew me to the company. It’s the only firm I’ve seen that provides a universal solution and customizes insulin prescription recommendations for nearly every conceivable insulin combination,” Yecies says.
“The best ideas in healthcare apply globally, with the ability to help patients both inside and outside the U.S., in the office or remotely. Mellitus Health’s software can help any insulin-using patient, anywhere. The telehealth potential is immense, as is its potential for use by physician extenders. It provides a tremendous clinical and administrative value proposition for enterprises, practices and patients.”